Wales Cancer Trials Unit: Clinical Trials

9 trials sponsored by Wales Cancer Trials Unit, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 1 completed, 1 terminated. 6 Phase 2, 3 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 26Unknown 4, Completed 1, Terminated 1
Phase 33Unknown 3
Not applicable1Unknown 1

Follow Wales Cancer Trials Unit: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vinorelbine in Mesothelioma
Vinorelbine, Active Symptom Control - Mesothelioma
Phase 2CompletedWales Cancer Trials Unit1542016-03-012021-10-12
Anticoagulation Length in Cancer Associated Thrombosis
Low Molecular Weight Heparin (LMWH) - Cancer, Thrombosis
Phase 2TerminatedCardiff University22013-12-012018-10-29
A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma
TroVax®, Pemetrexed, Cisplatin - Malignant, Pleural
Phase 2UnknownWales Cancer Trials Unit262012-12-012013-03-12
Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
caregiver-related intervention or procedure, questionnaire administration, quality-of-life assessment - Lung Cancer, Tobacco Use Disorder
Not applicableUnknownWales Cancer Trials Unit3862011-06-012013-08-26
Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
timing of surgery, gene expression analysis, biologic sample preservation procedure - Kidney Cancer
Phase 3UnknownEuropean Organisation for Research and Treatment of Cancer - EORTC992010-04-012017-02-08
First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer
carboplatin, vinorelbine tartrate, neuromuscular electrical stimulation - Chemotherapeutic Agent Toxicity, Fatigue
Phase 2UnknownWales Cancer Trials Unit522009-09-012011-08-08
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
questionnaire administration, quality-of-life assessment, robot-assisted laparoscopic surgery - Bladder Cancer
Phase 2UnknownWales Cancer Trials Unit922009-01-012011-04-01
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
cetuximab, capecitabine, cisplatin - Esophageal Cancer
Phase 2 / Phase 3UnknownWales Cancer Trials Unit2592008-02-012012-12-18
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
ibandronate sodium, zoledronic acid, Zolendronic Acid - Breast Cancer, Hypercalcemia of Malignancy
Phase 3UnknownWales Cancer Trials Unit14042006-01-012013-03-13

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Lung Neoplasms (2)  ·  Mesothelioma (2)  ·  Adenocarcinoma Of Esophagus (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Renal Cell (1)  ·  Esophageal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Fatigue (1)  ·  Humoral Hypercalcemia Of Malignancy (1)  ·  Kidney Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pulmonary Embolism (1)

Interventions

Cisplatin (2)  ·  Vinorelbine (2)  ·  Capecitabine (1)  ·  Carboplatin (1)  ·  Cetuximab (1)  ·  Dalteparin (1)  ·  Dexamethasone (1)  ·  Enoxaparin (1)  ·  Folic Acid (1)  ·  Gene Expression Profiling (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Ibandronic Acid (1)  ·  Pemetrexed (1)  ·  Radiotherapy (1)  ·  Therapeutics (1)

Countries

United Kingdom (8)  ·  Belgium (1)  ·  Canada (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Andrew Wilcock, MD (1)  ·  Axel Bex (1)  ·  Dean Fennell, Professor (1)  ·  Jason F Lester, FRCR, MRCP (1)  ·  John Kelly, MD (1)  ·  Peter J. Barrett Lee, MD (1)  ·  Richard Neal, MD (1)  ·  Simon Noble, Dr (1)  ·  Tom Crosby, MD (1)

Results publications

PMID 23228299, PMID 24279296, PMID 24332514, PMID 24338498, PMID 26490434, PMID 28072761, PMID 28274254, PMID 30075741, PMID 30543350, PMID 35313926, PMID 35706488